FCA
AGN

FinTrust Capital Advisors’s Allergan plc AGN Stock Holding History

FinTrust Capital Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-464
Closed -$82K – 1197
2020
Q1 		$82K Hold
464
– – 0.04% 319
2019
Q4 		$89K Sell
464
-10
-2% -$1.8K 0.04% 341
2019
Q3 		$80K Buy
474
+109
+30% +$17.8K 0.03% 370
2019
Q2 		$61K Sell
365
-50
-12% -$6.92K 0.02% 378
2019
Q1 		$61K Sell
415
-52
-11% -$7.54K 0.03% 353
2018
Q4 		$62K Buy
+467
New +$76.6K 0.03% 343

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

FinTrust Capital Advisors's AGN Position: Q2 2020 in Review

FinTrust Capital Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 464 shares — an estimated $82K sold.

FinTrust Capital Advisors first reported a position in AGN in Q4 2018 and held it in 6 quarters. The position peaked at $89K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • FinTrust Capital Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • FinTrust Capital Advisors sold 464 Allergan plc shares in Q2 2020, an estimated $82K.
  • FinTrust Capital Advisors first reported a position in Allergan plc in Q4 2018 and held it in 6 quarters.
  • FinTrust Capital Advisors's Allergan plc position peaked at $89K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on FinTrust Capital Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.